TrialJournal of translational medicine2019

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.

Marianna Alunni-Fabbroni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.